Avistone Pharmaceuticals
Beijing
About Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $340.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2023)
- Website: en.avistonebio.com
- Phone: 010- 84148921
Industries & Categories
Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/avistone-pharmaceuticals-65754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.